Find the right trial
for your patient

The AI uses publicly available eligibility criteria from ClinicalTrials.gov to evaluate whether your patient may qualify for each trial. It matches your description against inclusion and exclusion criteria for all actively enrolling trials at Swedish Cancer Institute and ranks them by fit. The Research Coordinator’s current notes are also checked and can override eligibility-based matches.

For some cancer types, a missing detail (like molecular profile or line of therapy) would significantly change which trials match. When that information is needed, the tool will ask before searching. You can always select “Search anyway” to proceed with the current description.

Trial availability changes continuously — trials open, close, reach enrollment caps, or update their eligibility criteria. Every search pulls live data. Always verify current status with the trial team before discussing enrollment with a patient.

After a search, tap the Share button next to the results. On iPhone and Android this opens your native share menu. On desktop it copies a formatted summary to your clipboard.

Trial data is pulled live from our database every time you search. Only actively enrolling and in start-up trials are shown.

Strong — trial explicitly targets the patient’s mutation/subtype and line of therapy matches. Possible — patient could be eligible but key criteria need verification. Unlikely — wrong line, stage, or an exclusion criterion is met. Worth considering — the trial is open to the patient’s tumor type and is plausible but in a different lane (typically pretreated cases or registry-style studies); these appear under “Also worth considering”. Results are organized into three sections: primary matches, trials worth considering, and non-treatment studies (registries, observational, supportive care).

These are trials that are open to the patient’s tumor type, but where the patient’s situation (line of therapy, cohort fit) makes them a secondary consideration rather than a primary match. They’re still worth a conversation with the trial team.

To keep the consultation focused. For additional questions, start a new session or contact the trial team directly using the button on each match card.

Built by the PSCI clinical trials team at Swedish Cancer Institute. For questions, use the “Contact about this trial” button on any result.